Aprepitant Capsules and Moxetumomab pasudotox
Determining the interaction of Aprepitant Capsules and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Moxetumomab Pasudotox-tdfk
- Aprepitant Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Aprepitant Capsules-Moxifloxacin
- Aprepitant Capsules-Moxifloxacin (Systemic)
- Aprepitant Capsules-Moxifloxacin Hydrochloride
- Aprepitant Capsules-Moxifloxacin Injection
- Moxetumomab pasudotox-Aprepitant Injection
- Moxetumomab pasudotox-Aprepitant Intravenous
- Moxetumomab pasudotox-Aprepitant Oral Suspension
- Moxetumomab pasudotox-Aprepitant/Fosaprepitant Dimeglumine
- Moxetumomab pasudotox-Apresazide
- Moxetumomab pasudotox-Apresoline